Have a personal or library account? Click to login
Bisphosphonate - Related Osteonecrosis of the Jaw – Five Years Experience Cover

Bisphosphonate - Related Osteonecrosis of the Jaw – Five Years Experience

Open Access
|Dec 2013

References

  1. 1. Stanton DC, Balasanian E. Outcome of surgical managment of Bisfosfonate-Related Osteonecrosis of the Jaws: Review of 33 Surgical Cases. J Oral Maxillofac Surg 2009 (67): 943−950.10.1016/j.joms.2008.12.057
  2. 2. Ruggiero SL, Dodson TB, Assael LA, Landesberg B, Marx RE, Mehrota B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisfosfonate-Related Osteonacrosis of the Jaws-2009 Update. J Oral Maxillofac Surg 2009, Suppl 1 (67): 2−12.10.1016/j.joms.2009.01.009
  3. 3. Marx RE. Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003 (61): 1 115.10.1016/S0278-2391(03)00720-1
  4. 4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 (62): 527-34.10.1016/j.joms.2004.02.004
  5. 5. Advisory Task Force on Bisfosfonate-Related Osteonacrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisfosfonate-Related Osteonacrosis of the Jaws. J Oral Maxillofac Surg 2007 (65): 369.10.1016/j.joms.2006.11.003
  6. 6. Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PAJ, Kreutsch T. “Bis-phossy jaws” - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Oral Maxillofac Surg 2008 (36):95-103.10.1016/j.jcms.2007.06.008
  7. 7. Tubiana-Hulin M, et al. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol/Hematol (2008), doi:10.1016/j.critrevonc.2008.10.00910.1016/j.critrevonc.2008.10.009
  8. 8. Allen MR, Burr DB. The Pathogenesis of Bisfosfonate-Related Osteonecrosis of the Jaw: So many Hypotheses, So Few Data, J Oral Maxillofac Surg 2009, Suppl 1 (67): 61−70.10.1016/j.joms.2009.01.007
  9. 9. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zolendronic acid and dexamethazone before dental extractions mimic bisphosphonate-realted osteonecrosis in cancer patients. Oral Oncology 2009 (45):164-172.10.1016/j.oraloncology.2008.04.013
  10. 10. Allen MR, Burr DB. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008 (66): 987.10.1016/j.joms.2008.01.038
  11. 11. Assael LA. Oral Bisfosfonates as a Ceuse of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of risks, and Preventive Strategies. J Oral Maxillofac Surg 2009, Suppl 1 (67): 35−43.10.1016/j.joms.2009.01.003
  12. 12. Capsoni F, Longhi M, Weinstein R. Bisphophonate-associated necrosis of the jaw> the rheumathologist’s role. Arthritis Res Ther 2006 (8):219.10.1186/ar2050
  13. 13. Woo SB, Hellstein JW, Kalmar JR. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws. Ann Intern Med 2006 (144):753-61.10.7326/0003-4819-144-10-200605160-00009
  14. 14. Woolhorton E. Patients retrieving intravenous bisphosphonates should avoid invasive dental procedures. CMAJ 172:1684, 200510.1503/cmaj.050640
  15. 15. Otto S, et al., Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic..., Journal of Cranio-Maxillo-Facial Surgery 2010, doi:10.1016/j.jcms.2010.05.00910.1016/j.jcms.2010.05.009
  16. 16. Arce K, Assael LA, Weissman JL, Markiewitz MR. Imaging Findings in Bisfosfonate-Related Osteonecrosis of Jaws. J Oral Maxillofac Surg 2009, Suppl 1 (67): 75−84.10.1016/j.joms.2008.12.002
  17. 17. Landesberg R, Cozin M, Cremers S, Woo V,Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S. IInhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 2008 (66):839-47.10.1016/j.joms.2008.01.026
  18. 18. Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Effect of zolendronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. British Journal of Haematology, 2008, doi: 10.1111/j.1365-2141.2008.07504.x10.1111/j.1365-2141.2008.07504.x
  19. 19. Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T. Yolendronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, withou causing osteonecrosis, in mice. J Bone Miner Metab 2010 (28):165-175.10.1007/s00774-009-0128-9
  20. 20. Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, Kirkpatrick CJ. Actinomycosis of the jaws - histopathological study of 45 patients shows involvement in bisphophonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch. 451:1009-1017, 200710.1007/s00428-007-0516-2
  21. 21. Gliklich R, Wilson J. Epidemiology of Bisphosphonate-Related Osteonecrosis of the Jaws: The Utility of a National Registry. J Oral Maxillofac Surg 2009 Suppl 1 (67): 71−74.10.1016/j.joms.2009.01.005
DOI: https://doi.org/10.2478/acm-2013-0015 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Language: English
Page range: 26 - 33
Published on: Dec 1, 2013
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year

© 2013 J Stilla, D Statelova, M Janickova, I Malachovsky, P Gengelova, J Jurkemik, K. Adamicova, published by Sciendo
This work is licensed under the Creative Commons License.